We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

148 hedge funds and large institutions have $318M invested in Spectrum Pharmaceuticals Inc in 2015 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 49 increasing their positions, 42 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

263% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 8

232% more call options, than puts

Call options by funds: $385K | Put options by funds: $116K

17% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 42

16% more funds holding

Funds holding: 128148 (+20)

15% less capital invested

Capital invested by funds: $375M → $318M (-$56.8M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
148
Holders Change
+20
Holders Change %
+15.63%
% of All Funds
4.13%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
29
Increased
49
Reduced
42
Closed
8
Calls
$385K
Puts
$116K
Net Calls
+$269K
Net Calls Change
-$453K
Name Holding Trade Value Shares
Change
Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$3.05M +$3.21M +462,425 +959%
RCAMU
27
Rothschild & Co Asset Management US
Connecticut
$3.02M -$428K -61,659 -11%
Wellington Management Group
28
Wellington Management Group
Massachusetts
$3M -$13.4M -1,933,580 -79%
BIM
29
Bogle Investment Management
Massachusetts
$2.69M +$3.12M +449,459 New
Principal Financial Group
30
Principal Financial Group
Iowa
$2.3M +$50.9K +7,336 +2%
Geode Capital Management
31
Geode Capital Management
Massachusetts
$2.28M +$16.9K +2,439 +0.6%
Connor, Clark & Lunn Investment Management (CC&L)
32
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.27M +$2.38M +342,200 +898%
SIM
33
Sonora Investment Management
Arizona
$1.85M +$2.05M +294,896 New
Ameriprise
34
Ameriprise
Minnesota
$1.73M -$70.3K -10,133 -3%
TC
35
TFS Capital
Pennsylvania
$1.71M +$1.99M +286,105 New
KCM
36
Kennedy Capital Management
Missouri
$1.71M +$1.08M +155,531 +120%
BIM
37
BlackRock Investment Management
Delaware
$1.67M -$9.59K -1,381 -0.5%
CIP
38
Convergence Investment Partners
Florida
$1.49M +$1.72M +248,302 New
DMK
39
David M. Knott
$1.45M
Arrowstreet Capital
40
Arrowstreet Capital
Massachusetts
$1.45M +$1.68M +242,222 New
Morgan Stanley
41
Morgan Stanley
New York
$1.38M +$1.37M +198,016 +602%
TCIM
42
TIAA CREF Investment Management
New York
$1.36M -$48.6K -6,994 -3%
Invesco
43
Invesco
Georgia
$1.35M +$223K +32,122 +17%
RFC
44
Russell Frank Company
Washington
$1.29M +$1.5M +215,700 New
Thrivent Financial for Lutherans
45
Thrivent Financial for Lutherans
Minnesota
$1.16M +$22.1K +3,190 +2%
American Century Companies
46
American Century Companies
Missouri
$1.15M +$1.33M +191,883 New
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$1.14M
PP
48
PDT Partners
New York
$1.12M +$1.06M +153,331 +448%
BA
49
Bard Associates
Illinois
$1.1M -$34.4K -4,950 -3%
Bank of Montreal
50
Bank of Montreal
Ontario, Canada
$835K -$7.87K -1,134 -0.8%

SPPI Hedge Fund Activity: Q3 2015 in Review

148 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q3 2015, worth a combined $318M — down 15% from $375M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new SPPI positions and 8 closed out — a net gain of 21 holders — while 49 added to existing stakes and 42 trimmed.

The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $9.13M. The largest seller was Armistice Capital, exiting entirely with an estimated $30.3M sold.

  • 148 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q3 2015, up from 128 in Q2 2015.
  • Funds reported $318M of Spectrum Pharmaceuticals Inc stock for Q3 2015, down 15% quarter-over-quarter.
  • 29 funds opened new Spectrum Pharmaceuticals Inc positions in Q3 2015 and 8 closed out, a net change of +21 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q3 2015 was Avoro Capital Advisors, an estimated $9.13M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q3 2015 was Armistice Capital, an estimated $30.3M sold.

Based on aggregated 13F filings for Q3 2015.